Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Nerac Insights / Articles / Erica Kramer, Ph.D. / The European In Vitro Diagnostic Regulation: It’s Time to Start Preparing

The European In Vitro Diagnostic Regulation: It’s Time to Start Preparing

Facebook0
Google+0
LinkedIn0
Twitter0
By Erica Kramer, Ph.D., Nerac Analyst
Originally Published: November 14, 2017

The global in vitro diagnostics (IVD) market was worth about $61.1 billion in 2016 and is projected to grow to $84.6 billion by 2023, with Europe accounting for the second largest market share after North America. The expected market growth, and increased interest in the field by consumers, makes in vitro diagnostics an attractive arena for research, development, and commercialization; however, market growth is expected to be hampered by factors such as price sensitive markets, inadequate reimbursement policies, and stringent government regulations, such as the new European in vitro diagnostics regulation. This article explores the significant changes manufacturers will notice. Read more here!

The article is free!

Simply fill in the form below, verify your email address
and you’ll be sent a link to download the article.
Please wait...
Loader

Related Posts

  • The European In Vitro Diagnostic Regulation: Performance Evaluation
    57
    By Erica Kramer, Ph.D., Senior Nerac Analyst/Medical Writer Originally Published: June 30, 2020 In May 2017, the European Parliament and Council published Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR), repealing Directive 98/79/EC (IVDD). The new regulation will apply starting May 26, 2022. Unlike under the IVDD, which allowed for self-certification for many…
    Tags: ivdr, manufacturers, published, european, regulation, vitro, read, diagnostic, erica, kramer
  • Without Clinical Data, European Compliance Can Appear Unattainable
    56
    By Robert Zott, Director of Advisory Services Development Originally published March 27, 2018 It’s easy to read Europe’s Clinical Evaluation Guidance Document MEDDEV 2.7/1 Revision 4 (referred to as “Rev. 4”) and come away with the impression that clinical data—whether in the form of investigations carried out by the manufacturer of a medical device or…
    Tags: explores, read, published, european, originally, article, medical, device, regulations, eu
  • Are Your Devices State-of-the-Art?
    52
    By Ron Sills, Nerac Analyst Originally Published: September 29th, 2014 The European Union’s Council Directive  93/42/EEC concerning medical devices  contains the essential requirements to be met by medical device manufacturers in order to market their products in the 28 member countries.  A technical file for Class IIa and IIb devices, or a design dossier for…
    Tags: medical, device, manufacturers, read, analyst, originally, nerac, published, european, changes
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence Disruptive Technologies emerging markets energy EU MDR FDA food helga weires Industry 4.0 innovation Inspiring Next intellectual property intellectual property strategies IP market analysis market research medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation Order 650 patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance Robert Beinstein Rosemarie Szostak specialty chemicals Sustainable Development Goals technology scouting XcellR8
  • Facebook
  • Google+
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities
  • Privacy Policy

Copyright © 2022 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!
  • This field is for validation purposes and should be left unchanged.